Nasdaq - Delayed Quote • USD
VALIC Company I - Health Sciences Fund (VCHSX)
At close: May 11 at 8:01 PM EDT
Fund Summary
The fund normally invests at least 80% of its net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-cap companies. The fund may invest up to 35% of its total assets in foreign stocks, which include non-dollar denominated securities traded outside the U.S.
VALIC Company I - Health Sciences Fund
AIG Retirement CO I
2929 Allen Parkway A8-10
Fund Overview
Category | Health |
Fund Family | VALIC |
Net Assets | 966.13M |
YTD Return | -0.22% |
Yield | 0.00% |
Morningstar Rating | |
Inception Date | Nov 01, 2000 |
Fund Operations
Last Dividend | 0.00 |
Last Cap Gain | 0.00 |
Holdings Turnover | 37.00% |
Average for Category | -- |
Fees & Expenses
Expense | VCHSX | Category Average |
---|---|---|
Annual Report Expense Ratio (net) | 1.05% | 1.03% |
Prospectus Net Expense Ratio | 1.05% | -- |
Prospectus Gross Expense Ratio | 1.09% | -- |
Max 12b1 Fee | -- | -- |
Max Front End Sales Load | -- | 5.37% |
Max Deferred Sales Load | -- | 1.19% |
3 Yr Expense Projection | 343 | -- |
5 Yr Expense Projection | 597 | -- |
10 Yr Expense Projection | 1,325 | -- |
Management Information
Ziad Bakri, Lead Manager since April 01, 2016
Ziad Bakri joined T. Rowe Price in 2011 and has since been a key member of the healthcare research team, influencing investment decisions and making significant contributions to the stock selections. Ziad has had a long track record of analyzing biotechnology companies, a key sector within the healthcare industry. Ziad brings a unique perspective to his new role, having been a medical doctor and an emergency medicine resident at the Royal London Hospital before beginning his investment career. Prior to joining T. Rowe Price, Ziad held biotechnology equity research and healthcare investment ban Morningstar Style Box
Morningstar Category
Related Tickers
RYVYX Rydex NASDAQ-100 2x Strategy H
428.48
+3.00%
RYVLX Rydex NASDAQ-100 2x Strategy A
428.60
+3.00%
UOPIX ProFunds UltraNASDAQ-100 Inv
84.99
+2.99%
RYCCX Rydex NASDAQ-100 2x Strategy Fund
309.48
+2.99%
UOPSX ProFunds UltraNASDAQ-100 Svc
58.63
+2.99%
FSMEX Fidelity Select Medical Tech and Devcs
63.92
+2.98%
INPSX ProFunds Internet UltraSector Svc
27.14
+2.96%
INPIX ProFunds Internet UltraSector Inv
42.34
+2.94%
FSELX Fidelity Select Semiconductors
28.28
+2.80%
FELTX Fidelity Advisor Semiconductors M
66.45
+2.75%
FELIX Fidelity Advisor Semiconductors I
76.99
+2.75%
FIKGX Fidelity Advisor Semiconductors Z
77.15
+2.74%
FELCX Fidelity Advisor Semiconductors C
56.93
+2.74%
FELAX Fidelity Advisor Semiconductors A
71.18
+2.74%
LGLIX Lord Abbett Growth Leaders I
38.52
+2.69%
LGLUX Lord Abbett Growth Leaders R5
38.54
+2.69%
LGLFX Lord Abbett Growth Leaders F
38.17
+2.69%
LGLAX Lord Abbett Growth Leaders A
36.69
+2.69%
LGLQX Lord Abbett Growth Leaders R2
35.19
+2.68%
LGLRX Lord Abbett Growth Leaders R3
35.25
+2.68%
LGLOX Lord Abbett Growth Leaders F3
38.86
+2.67%
LGLVX Lord Abbett Growth Leaders R6
38.86
+2.67%
LGLSX Lord Abbett Growth Leaders R4
36.70
+2.66%
LGLCX Lord Abbett Growth Leaders C
31.38
+2.65%
OSTGX Osterweis Emerging Opportunity
15.41
+2.60%
DVSMX Driehaus Small Cap Growth Investor
20.25
+2.58%
DNSMX Driehaus Small Cap Growth Institutional
20.66
+2.58%
ARTYX Artisan Developing World Investor
18.00
+2.56%
APDYX Artisan Developing World Fund
18.19
+2.54%
NEEGX Needham Growth Retail
65.02
0.00%
APHDX Artisan Global Discovery Fund
19.11
+2.52%
APHYX Artisan Developing World Fund
18.31
+2.52%
UMPSX ProFunds UltraMid Cap Svc
47.25
+2.52%
UMPIX ProFunds UltraMid Cap Inv
61.24
+2.51%
APFDX Artisan Global Discovery Fund
18.90
+2.49%
APDDX Artisan Global Discovery Fund
18.97
+2.49%
NPSGX Nicholas Partners Small Cap Gr Instl
15.07
+2.38%
BIOIX Baron Opportunity Instl
40.61
+2.32%
BIOUX Baron Opportunity R6
40.65
+2.32%
BIOPX Baron Opportunity Retail
38.10
+2.31%
VRMGX Virtus KAR Mid-Cap Growth R6
58.75
+2.30%
PICMX Virtus KAR Mid-Cap Growth Fund
58.03
+2.29%
FAGAX Fidelity Advisor Growth Opps A
142.01
+2.29%
FAGCX Fidelity Advisor Growth Opps I
157.66
+2.29%
FAGOX Fidelity Advisor Growth Opps M
139.37
+2.29%
FZAHX Fidelity Advisor Growth Opportunities Fund
159.96
+2.29%
FACGX Fidelity Advisor Growth Opps C
113.58
+2.28%
PSKCX Virtus KAR Mid-Cap Growth C
41.80
+2.28%
FTQGX Fidelity Focused Stock
35.96
+2.28%
PHSKX Virtus KAR Mid-Cap Growth Fund
55.50
+2.27%
VWIGX Vanguard International Growth Inv
32.98
+2.26%
FTRNX Fidelity Trend
166.58
+2.26%
VWILX Vanguard International Growth Adm
104.88
+2.24%
BDFFX Baron Discovery Retail
26.28
+2.22%
BDFUX Baron Discovery R6
27.01
+2.19%
BDFIX Baron Discovery Institutional
27.01
+2.19%
FSPTX Fidelity Select Technology
30.35
+2.19%
BGSRX BlackRock Technology Opportunities R
55.11
+2.19%
BSTSX BlackRock Technology Opportunities Svc
56.52
+2.19%
BGSAX BlackRock Technology Opportunities Inv A
55.14
+2.19%
FATIX Fidelity Advisor Technology I
114.57
+2.19%
FADTX Fidelity Advisor Technology A
101.48
+2.19%
FTHCX Fidelity Advisor Technology C
74.36
+2.18%
FIKHX Fidelity Advisor Technology Z
114.58
+2.18%
BGSIX BlackRock Technology Opportunities Instl
60.83
+2.18%
BTEKX BlackRock Technology Opportunities K
60.99
+2.18%
BGSCX BlackRock Technology Opportunities Inv C
43.67
+2.18%
FATEX Fidelity Advisor Technology M
92.21
+2.17%
MMEYX Victory Integrity Discovery Fund
44.42
+2.16%
PRMTX T. Rowe Price Comm & Tech Investor
132.91
+2.16%
TTMIX T. Rowe Price Comm & Tech I
133.51
+2.16%
RYSAX Rydex Electronics H
340.07
+2.15%
MMECX Victory Integrity Discovery Fund
23.73
+2.15%
RYSIX Rydex Electronics Inv
385.92
+2.15%
RYELX Rydex Electronics Fund
350.97
+2.15%
RYSCX Rydex Electronics C
297.11
+2.15%
EPGAX Fidelity Advisor Equity Growth A
19.02
+2.15%
FZAFX Fidelity Advisor Equity Growth Fund
22.41
+2.14%
MMEAX Victory Integrity Discovery Fund
39.11
+2.14%
MMMMX Victory Integrity Discovery Fund
39.22
+2.14%
EQPGX Fidelity Advisor Equity Growth I
22.07
+2.13%
FAEGX Fidelity Advisor Equity Growth M
18.29
+2.12%
PRJBX PGIM Jennison Global Opportunities R2
42.40
+2.12%
PRJAX PGIM Jennison Global Opportunities A
42.04
+2.11%
PRJDX PGIM Jennison Global Opportunities R4
43.03
+2.11%
PRJQX PGIM Jennison Global Opportunities R6
43.60
+2.11%
PRJCX PGIM Jennison Global Opportunities C
37.79
+2.11%
ALZFX Alger Focus Equity Z
61.11
+2.11%
ALAFX Alger Focus Equity A
58.71
+2.10%
PRJZX PGIM Jennison Global Opportunities Z
43.19
+2.10%
ALGYX Alger Focus Equity Y
61.33
+2.10%
FDSVX Fidelity Growth Discovery
60.10
+2.09%
ALGRX Alger Focus Equity I
59.19
+2.09%
ALCFX Alger Focus Equity C
52.86
+2.09%
FGDKX Fidelity Growth Discovery K
60.22
+2.09%
JLGZX JPMorgan Large Cap Growth R2
61.00
+2.06%
JLGPX JPMorgan Large Cap Growth R3
65.64
+2.05%
OLGAX JPMorgan Large Cap Growth A
65.21
+2.05%
OLGCX JPMorgan Large Cap Growth C
42.87
+2.05%
PWJZX PGIM Jennison International Opps Z
29.92
+2.05%